The Cooper Companies, Inc.
COOHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeThe Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. Valued at $11.64B, COO is a large-cap name in its sector. The company operates in two segments, CooperVision and CooperSurgical.
Market Cap
$11.64B
Beta
0.82
P/E (TTM)
21.18
P/E (Fwd)
13.04
EPS (TTM)
$2.89
EPS (Fwd)
$4.69
ROE
6.8%
ROA
2.7%
Cash
$154.7M
Total Debt
$2.80B
Free CF
$542.6M
52W Change
-16.7%
Annual Financials
Cash vs Debt
Where COO stands vs its 150-day and 200-day moving averages
As of the September 30, 2026 close, COO finished 17.07% below its 150-day moving average ($68.29) and 21.07% below its 200-day moving average ($71.75). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is COO overbought or oversold?
At the September 30, 2026 close, COO's RSI(14) was 32.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $154.7M in cash, though total debt stands at $2.80B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $542.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 6.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $3.31B (2022) to $4.09B (2025), reflecting a 24% increase over the period.
The Cooper Companies, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing COO.